| RS121909668 |
FUS
|
Health Risk |
Pathogenic |
Amyotrophic lateral sclerosis type 6, Tremor |
| RS121909669 |
FUS
|
Health Risk |
Pathogenic |
Amyotrophic lateral sclerosis type 6, Tremor |
| RS121909671 |
FUS
|
Health Risk |
Pathogenic/Likely pathogenic |
Amyotrophic lateral sclerosis type 6, Tremor |
| RS121909672 |
GABRG2
|
Health Risk |
Pathogenic |
Febrile seizures, familial |
| RS121909673 |
GABRG2
|
Health Risk |
Likely pathogenic |
EPILEPSY, CHILDHOOD ABSENCE |
| RS121909674 |
GABRG2
|
Health Risk |
Pathogenic |
Febrile seizures, familial |
| RS121909675 |
GGCX
|
Health Risk |
Pathogenic |
Vitamin K-dependent clotting factors, combined deficiency of |
| RS121909676 |
GGCX
|
Health Risk |
Pathogenic |
Vitamin K-dependent clotting factors, combined deficiency of |
| RS121909677 |
GGCX
|
Health Risk |
Pathogenic |
Body skin hyperlaxity due to vitamin K-dependent coagulation factor deficiency, Body skin hyperlaxity due to vitamin K-dependent coagulation factor deficiency |
| RS121909678 |
GGCX
|
Health Risk |
Pathogenic |
Body skin hyperlaxity due to vitamin K-dependent coagulation factor deficiency, Body skin hyperlaxity due to vitamin K-dependent coagulation factor deficiency |
| RS121909679 |
GGCX
|
Health Risk |
Pathogenic |
Body skin hyperlaxity due to vitamin K-dependent coagulation factor deficiency, Body skin hyperlaxity due to vitamin K-dependent coagulation factor deficiency |
| RS121909680 |
GGCX
|
Health Risk |
Pathogenic |
Body skin hyperlaxity due to vitamin K-dependent coagulation factor deficiency, Body skin hyperlaxity due to vitamin K-dependent coagulation factor deficiency |
| RS121909681 |
GGCX
|
Health Risk |
Pathogenic |
Body skin hyperlaxity due to vitamin K-dependent coagulation factor deficiency, Body skin hyperlaxity due to vitamin K-dependent coagulation factor deficiency |
| RS121909682 |
GGCX
|
Health Risk |
Pathogenic |
Body skin hyperlaxity due to vitamin K-dependent coagulation factor deficiency, Body skin hyperlaxity due to vitamin K-dependent coagulation factor deficiency |
| RS121909683 |
GGCX
|
Health Risk |
Pathogenic/Likely pathogenic |
Body skin hyperlaxity due to vitamin K-dependent coagulation factor deficiency, Vitamin K-dependent clotting factors |
| RS121909715 |
GSN
|
Health Risk |
Pathogenic/Likely pathogenic |
Finnish type amyloidosis, Inborn genetic diseases |
| RS121909717 |
GFAP
|
Health Risk |
Pathogenic |
Alexander disease, Inborn genetic diseases |
| RS121909718 |
GFAP
|
Health Risk |
Pathogenic |
Alexander disease, Alexander disease |
| RS121909719 |
GFAP
|
Health Risk |
Pathogenic |
Alexander disease, Alexander disease |
| RS121909720 |
GFAP
|
Health Risk |
Pathogenic |
Alexander disease, Alexander disease |
| RS121909721 |
MPV17
|
Health Risk |
Pathogenic |
Mitochondrial DNA depletion syndrome 6 (hepatocerebral type), Mitochondrial DNA depletion syndrome |
| RS121909722 |
MPV17
|
Health Risk |
Pathogenic |
Mitochondrial DNA depletion syndrome 6 (hepatocerebral type), Mitochondrial DNA depletion syndrome 6 (hepatocerebral type) |
| RS121909723 |
MPV17
|
Health Risk |
Pathogenic |
Mitochondrial DNA depletion syndrome 6 (hepatocerebral type), Mitochondrial DNA depletion syndrome 15 (hepatocerebral type) |
| RS121909724 |
MPV17
|
Health Risk |
Pathogenic/Likely pathogenic |
Mitochondrial DNA depletion syndrome 6 (hepatocerebral type), Charcot-Marie-Tooth disease |
| RS121909726 |
NR3C1
|
Health Risk |
Pathogenic |
GLUCOCORTICOID RESISTANCE, CELLULAR |
| RS121909727 |
NR3C1
|
Health Risk |
Pathogenic |
Glucocorticoid resistance, Glucocorticoid resistance |
| RS121909730 |
GLUD1
|
Health Risk |
Pathogenic/Likely pathogenic |
Hyperinsulinism-hyperammonemia syndrome, Familial hyperinsulinemia |
| RS121909731 |
GLUD1
|
Health Risk |
Pathogenic |
Hyperinsulinism-hyperammonemia syndrome, Hyperinsulinism-hyperammonemia syndrome |
| RS121909733 |
GLUD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hyperinsulinism-hyperammonemia syndrome, Hyperinsulinism-hyperammonemia syndrome |
| RS121909734 |
GLUD1
|
Health Risk |
Likely pathogenic |
Hyperinsulinism-hyperammonemia syndrome, Hyperinsulinism-hyperammonemia syndrome |
| RS121909735 |
GLUD1
|
Health Risk |
Pathogenic |
Hyperinsulinism-hyperammonemia syndrome, Hyperinsulinism-hyperammonemia syndrome |
| RS121909736 |
GLUD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hyperinsulinism-hyperammonemia syndrome, Hyperinsulinism-hyperammonemia syndrome |
| RS121909737 |
GLUD1
|
Health Risk |
Pathogenic/Likely pathogenic |
Hyperinsulinism-hyperammonemia syndrome, Hyperinsulinism-hyperammonemia syndrome |
| RS121909739 |
SLC2A1
|
Health Risk |
Pathogenic |
Childhood onset GLUT1 deficiency syndrome 2, GLUT1 deficiency syndrome 1 |
| RS121909740 |
SLC2A1
|
Health Risk |
Pathogenic/Likely pathogenic |
Childhood onset GLUT1 deficiency syndrome 2, Encephalopathy due to GLUT1 deficiency |
| RS121909741 |
SLC2A2
|
Health Risk |
Likely pathogenic |
Fanconi-Bickel syndrome, Fanconi-Bickel syndrome |
| RS121909742 |
SLC2A2
|
Health Risk |
Pathogenic |
Fanconi-Bickel syndrome, Type 2 diabetes mellitus |
| RS121909743 |
SLC2A2
|
Health Risk |
Pathogenic |
Fanconi-Bickel syndrome, Type 2 diabetes mellitus |
| RS121909744 |
SLC2A2
|
Health Risk |
Pathogenic/Likely pathogenic |
Fanconi-Bickel syndrome, Fanconi-Bickel syndrome |
| RS121909745 |
SLC2A2
|
Health Risk |
Pathogenic |
Fanconi-Bickel syndrome, Fanconi-Bickel syndrome |
| RS121909746 |
SLC2A2
|
Health Risk |
Pathogenic |
Fanconi-Bickel syndrome, Fanconi-Bickel syndrome |
| RS121909747 |
SLC2A2
|
Health Risk |
Pathogenic |
Fanconi-Bickel syndrome, Fanconi-Bickel syndrome |
| RS121909748 |
CFB
|
Health Risk |
Pathogenic |
Atypical hemolytic-uremic syndrome with B factor anomaly, Atypical hemolytic-uremic syndrome |
| RS121909749 |
GLRB
|
Health Risk |
Pathogenic |
Hyperekplexia 2, Hyperekplexia 2 |
| RS121909750 |
GP1BB
|
Health Risk |
Conflicting classifications of pathogenicity |
MACROTHROMBOCYTOPENIA, FAMILIAL |
| RS121909751 |
GP1BB
|
Health Risk |
Pathogenic |
MACROTHROMBOCYTOPENIA, FAMILIAL |
| RS121909752 |
GP1BB
|
Health Risk |
Likely pathogenic |
Bernard-Soulier syndrome, type B |
| RS121909761 |
ADGRV1
|
Health Risk |
Pathogenic |
Febrile seizures, familial |
| RS121909762 |
ADGRV1
|
Health Risk |
Pathogenic/Likely pathogenic |
Usher syndrome type 2C, Usher syndrome |
| RS121909763 |
ADGRV1
|
Health Risk |
Pathogenic |
Usher syndrome type 2C, Usher syndrome type 2C |
| RS121909764 |
DHCR7
|
Health Risk |
Pathogenic/Likely pathogenic |
Smith-Lemli-Opitz syndrome, DHCR7-related disorder |
| RS121909765 |
DHCR7
|
Health Risk |
Pathogenic/Likely pathogenic |
Smith-Lemli-Opitz syndrome, Inborn genetic diseases |
| RS121909766 |
DHCR7
|
Health Risk |
Pathogenic/Likely pathogenic |
Smith-Lemli-Opitz syndrome, DHCR7-related disorder |
| RS121909767 |
DHCR7
|
Health Risk |
Pathogenic/Likely pathogenic |
Smith-Lemli-Opitz syndrome, Smith-Lemli-Opitz syndrome |
| RS121909768 |
DHCR7
|
Health Risk |
Pathogenic |
Smith-Lemli-Opitz syndrome, Smith-Lemli-Opitz syndrome |
| RS121909770 |
SIX1
|
Health Risk |
Pathogenic |
Branchiootic syndrome 3, Branchiootic syndrome 3 |
| RS121909775 |
CASP10
|
Health Risk |
Pathogenic |
Non-Hodgkin lymphoma, Gastric cancer |
| RS121909790 |
VDR
|
Health Risk |
Pathogenic |
Vitamin D-dependent rickets type II with alopecia, Vitamin D-dependent rickets type II with alopecia |
| RS121909791 |
VDR
|
Health Risk |
Pathogenic/Likely pathogenic |
Vitamin D-dependent rickets type II with alopecia, Vitamin D-dependent rickets type II with alopecia |
| RS121909792 |
VDR
|
Health Risk |
Pathogenic |
Vitamin D-dependent rickets type II with alopecia, Vitamin D-dependent rickets type II with alopecia |
| RS121909793 |
VDR
|
Health Risk |
Conflicting classifications of pathogenicity |
Vitamin D-dependent rickets type II with alopecia, Vitamin D-dependent rickets type II with alopecia |
| RS121909794 |
VDR
|
Health Risk |
Pathogenic |
Vitamin D-dependent rickets type II with alopecia, Vitamin D-dependent rickets type II with alopecia |
| RS121909795 |
VDR
|
Health Risk |
Pathogenic |
Vitamin D-dependent rickets type II with alopecia, Vitamin D-dependent rickets type II with alopecia |
| RS121909796 |
VDR
|
Health Risk |
Pathogenic/Likely pathogenic |
Vitamin D-dependent rickets type II with alopecia, Vitamin D-dependent rickets type II with alopecia |
| RS121909797 |
VDR
|
Health Risk |
Pathogenic |
Vitamin D-dependent rickets type II with alopecia, Vitamin D-dependent rickets type II with alopecia |
| RS121909798 |
VDR
|
Health Risk |
Pathogenic |
Vitamin D-dependent rickets type II with alopecia, Vitamin D-dependent rickets type II with alopecia |
| RS121909800 |
VDR
|
Health Risk |
Pathogenic |
Vitamin D-dependent rickets type II with alopecia, Vitamin D-dependent rickets type II with alopecia |
| RS121909801 |
VDR
|
Health Risk |
Pathogenic |
Vitamin D-dependent rickets type II with alopecia, Vitamin D-dependent rickets type II with alopecia |
| RS121909802 |
VDR
|
Health Risk |
Conflicting classifications of pathogenicity |
Vitamin D-dependent rickets type II with alopecia, Vitamin D-dependent rickets type II with alopecia |
| RS121909803 |
HBA2
|
Health Risk |
Pathogenic |
Hemoglobin H disease, nondeletional |
| RS121909833 |
NSDHL
|
Health Risk |
Pathogenic |
CK syndrome, CK syndrome |
| RS121909834 |
NSDHL
|
Health Risk |
Pathogenic |
CK syndrome, CK syndrome |
| RS121909835 |
PDE6A
|
Health Risk |
Pathogenic |
Retinitis pigmentosa 43, Retinal dystrophy |
| RS1219104992 |
PCARE
|
Health Risk |
Pathogenic |
— |
| RS1219118149 |
ATP1A2
|
Health Risk |
Likely pathogenic |
Familial hemiplegic migraine, Familial hemiplegic migraine |
| RS121912195 |
DHCR7
|
Health Risk |
Pathogenic/Likely pathogenic |
Smith-Lemli-Opitz syndrome, Inborn genetic diseases |
| RS121912243 |
CHRNA4
|
Health Risk |
Conflicting classifications of pathogenicity |
Tobacco use disorder, Inborn genetic diseases |
| RS121912244 |
CHRNA4
|
Health Risk |
Conflicting classifications of pathogenicity |
Tobacco use disorder, Autosomal dominant nocturnal frontal lobe epilepsy |
| RS121912253 |
CHRNA4
|
Health Risk |
Conflicting classifications of pathogenicity |
Tobacco use disorder, Autosomal dominant nocturnal frontal lobe epilepsy |
| RS121912267 |
CHRNA4
|
Health Risk |
Conflicting classifications of pathogenicity |
Tobacco use disorder, Autosomal dominant nocturnal frontal lobe epilepsy |
| RS121912268 |
CHRNA4
|
Health Risk |
Conflicting classifications of pathogenicity |
Tobacco use disorder, Autosomal dominant nocturnal frontal lobe epilepsy |
| RS121912274 |
CHRNA4
|
Health Risk |
Conflicting classifications of pathogenicity |
Tobacco use disorder, Autosomal dominant nocturnal frontal lobe epilepsy |
| RS121912277 |
CHRNA4
|
Health Risk |
Conflicting classifications of pathogenicity |
Tobacco use disorder, Autosomal dominant nocturnal frontal lobe epilepsy |
| RS121912278 |
CHRNA4
|
Health Risk |
Conflicting classifications of pathogenicity |
Tobacco use disorder, Autosomal dominant nocturnal frontal lobe epilepsy |
| RS121912280 |
CHRNA4
|
Health Risk |
Conflicting classifications of pathogenicity |
Tobacco use disorder, Autosomal dominant nocturnal frontal lobe epilepsy |
| RS121912281 |
CHRNA4
|
Health Risk |
Conflicting classifications of pathogenicity |
Tobacco use disorder, Autosomal dominant nocturnal frontal lobe epilepsy |
| RS121912282 |
CHRNA4
|
Health Risk |
Conflicting classifications of pathogenicity |
Tobacco use disorder, Autosomal dominant nocturnal frontal lobe epilepsy |
| RS121912283 |
CHRNA4
|
Health Risk |
Conflicting classifications of pathogenicity |
Tobacco use disorder, Autosomal dominant nocturnal frontal lobe epilepsy |
| RS121912288 |
DKC1
|
Health Risk |
Pathogenic |
Dyskeratosis congenita, X-linked |
| RS121912289 |
DKC1
|
Health Risk |
Likely pathogenic |
Dyskeratosis congenita, X-linked |
| RS121912290 |
DKC1
|
Health Risk |
Likely pathogenic |
Dyskeratosis congenita, X-linked |
| RS121912292 |
DKC1
|
Health Risk |
Pathogenic |
Dyskeratosis congenita, X-linked |
| RS121912293 |
DKC1
|
Health Risk |
Pathogenic |
Dyskeratosis congenita, X-linked |
| RS121912294 |
DKC1
|
Health Risk |
Pathogenic |
Dyskeratosis congenita, X-linked |
| RS121912295 |
DKC1
|
Health Risk |
Pathogenic |
Dyskeratosis congenita, X-linked |
| RS121912297 |
DKC1
|
Health Risk |
Pathogenic/Likely pathogenic |
Dyskeratosis congenita, X-linked |
| RS121912303 |
DKC1
|
Health Risk |
Conflicting classifications of pathogenicity |
Dyskeratosis congenita, X-linked |
| RS121912304 |
DKC1
|
Health Risk |
Pathogenic |
Dyskeratosis congenita, X-linked |
| RS121912305 |
DKC1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hoyeraal-Hreidarsson syndrome, Dyskeratosis congenita |
| RS121912307 |
MAFB
|
Health Risk |
Conflicting classifications of pathogenicity |
Multicentric carpo-tarsal osteolysis with or without nephropathy, Duane retraction syndrome 3 with or without deafness |